FDA
-
-
-
-
-
-
-
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
-
-
-
-
-
-
-
Theratechnologies Announces Path to Resume TH1902 Clinical Development
-
-
-
-
-
-
-
Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens
-
-
-
-
-
-
-
THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORY
-
-
-
-
-
-
-
Theratechnologies (THTX) Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology for Targeting SORT1-Mediated Vasculogenic Mimicry
-
-
-
-
-
-
-
Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers
-
-
-
-
-
-
-
Theratechnologies Announces Fourth Quarter and Fiscal Year 2020 Financial Results
-
249,557 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All